NOVARTIS for NOVARTIS
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S.1145 Patent Reform Act of 2007 H.R.1908 Patent Reform Act of 2007
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARGUERITE BAXTER | — |
| DANIEL CASSERLY | — |
| DAVID DRAKE | — |
| JAMES ELKIN | — |
| THOMAS GILES | — |
| SARAH HALLER | — |
| GENE HUGHES | — |
| KATHERINE SOLON | — |
Trade (domestic/foreign) TRD
Free Trade Agreements: - Intellectual Property Provisions in Peru, Columbia, Korea
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RENARD ARON | — |
| SARAH HALLER | — |
Health Issues HCR
HR4703, S2467, HR4991 - Vaccine Shortage Preparedness Act of 2008 S2464, HR4992, HR4704 - A bill to amend title XVIII of the Social Security Act to provide for coverage of federally recommended vaccines under Medicare part B S. 2465, HR 4702, HR 4990 A bill to amend title XIX of the Social Security Act to include all public clinics for the distribution of pediatric vaccines under the Medicaid program. S. 2467, HR 4703, HR 4991 A bill to amend the Social Security Act, the Federal Food, Drug and Cosmetic Act, and the Public Health Service Act to ensure a sufficient supply of vaccines, and for other purposes. HR4705 - Vaccines for the Uninsured Adult Act of 2008 S3678 H.R. 970 and S. 1378 - Dextromethorphan Distribution Act of 2007 S.3678 Pandemic All Hazards Preparedness Act (Biodefense) S.103 Combat Meth Act of 2005 H.R. 2207 - Agricultural Disaster Assistance and Western States Emergency Unfinished Business Appropriations Act of 2007 H.R. 1908 and S. 1710 - Patent Reform Act of 2007 H.R 1 - Implementing the 9/11 Commission Recommendations Act of 2007 H.R. 3162 - Children's Health and Medicare Protection Act of 2007 S. 1505 Affordable Biologics for Consumers Act S. 1695 Biologics Price Competition and Innovation Act of 2007 H.R. 1956 Patient Protection and Innovative Biologic Medicines Act of 2007 H.R. 1038 Access to Life-Saving Medicine Act S.623 Access to Life-Saving Medicine Act H.R. 4083 Non-Prescription Drug Modernization Act of 2007 S. 2311 Non-Prescription Drug Modernization Act of 2007 Comparative Effectiveness Research Public Health Service Act Drug Importation Gene Therapy Direct to Consumer Advertising Drug Safety Legislation Global Hypertension Best Pharmaceuticals for Children's Act Pediatric Research Equity Act Pharmaceuticals in water FDA Funding Reagan/Udall Foundation Counter Detailing
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARGUERITE BAXTER | — |
| DANIEL CASSERLY | — |
| DAVID DRAKE | — |
| JAMES ELKIN | — |
| THOMAS GILES | — |
| SARAH HALLER | — |
| GENE HUGHES | — |
| KATHERINE SOLON | — |
Medicare/Medicaid MMM
S. 2029 Physician Payments Sunshine Act of 2007 H.R. 6111 Tax Relief and health Care Act (Medicare) Access to Life Saving Medicines Act Medicare Part B and Part D - Part D: Non-Interference Part B: Prompt Pay Removal from Average Sales Price Calculation Immunosuppressant Legislation Medicare Prescription Drugs and Modernization Act H.R.2184 Enhanced Health Care Value for All Act of 2007 H.R.3023 Drug and Medical Device Company Gift Disclosure Act H.R. 3963Children's Health Insurance Program Reauthorization Act of 2007 S.2041 False Claims Act Correction Act of 2007 HR 4854 False Claims Act Correction Act of 2007 HR3610 Food and Drug Import Safety Act of 2007
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARGUERITE BAXTER | — |
| DANIEL CASSERLY | — |
| DAVID DRAKE | — |
| JAMES ELKIN | — |
| THOMAS GILES | — |
| SARAH HALLER | — |
| GENE HUGHES | — |
| KATHERINE SOLON | — |
Budget/Appropriations BUD
DoD Authorization language - Section 701, Dealing with TriCare H.R. 3282 - Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2007 FY 2009 Labor HHS Appropriations Bill - Pandemic Influenza Funding and Weldon Ammendment on Thimerosal and Vaccines 2009 Supplemental Appropriations Bill FY 2009 Department of Defense Appropriations Bill - Transformational Medical Technologies Initiative
Foreign entity interest: Novartis AG to the degree that public policies, either laws or regulations, commercially benefit Novartis Corporation, so too Novartis AG, as its parent, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARGUERITE BAXTER | — |
| DANIEL CASSERLY | — |
| DAVID DRAKE | — |
| JAMES ELKIN | — |
| THOMAS GILES | — |
| SARAH HALLER | — |
| GENE HUGHES | — |
| KATHERINE SOLON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.